Could cause temporary or reversible harm; serious harm is unlikely.
cGMP Deviations
| Distributed by / for | RemedyRepack Inc. |
| NDC | 70518-1946-00 |
| Full product label | Atorvastatin 10 mg tablets, packaged in a) 30-count bottles (NDC 70518-1946-00) and b) 90-count bottles (NDC 70518-1946-01), Rx only, Repackaged by: RemedyRepack Inc., Indiana, PA 15701. |
| Recalling firm | RemedyRepack Inc. |
| Distribution | RemedyRepack distributed product to consignees nationwide within the United States |
| Quantity | a) 3,497 bottles, b) 729 bottles |
| Recall initiated | 2023-03-20 |
| Report date | 2023-04-12 |
| Recall completed | 2023-10-19 |
| Recall number | D-0491-2023 |
| Classification | Class II |
| FDA status | Terminated |
| Origin on file | Indiana PA United States |
Source: U.S. FDA enforcement database (openFDA). Look this up on the official FDA recalls site ↗